In recent years, the gap in the rate of opioid overdoses among Black and white Americans has narrowed significantly, with increases in Black mortality driven in part by the addition of synthetic opioids to other drugs. Despite the more pressing need for treatment, Black Americans have less access to treatment with buprenorphine than white Americans. In this issue brief,  In a new issue brief, three FORE grantees — Helena Hansen, M.D., Ph.D., Ayana Jordan, M.D., Ph.D., and Hansel Tookes, M.D., M.P.H. — describe how they are working to identify gaps in care and promising approaches to close them.describe how they are working to identify gaps in care and promising approaches to close them.